The biogenesis of platelets from megakaryocyte proplatelets

Journal of Clinical Investigation

Volumn 115, Issue 12, 2005, Pages 3348-3354

  Patel, Sunita R ^a   Hartwig, John H ^a   Italiano Jr , Joseph E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNEIN ADENOSINE TRIPHOSPHATASE; TRANSCRIPTION FACTOR GATA 1;

ACTIN FILAMENT; ALPORT SYNDROME; BERNARD SOULIER DISEASE; BIOGENESIS; CENTROSOME; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MAY HEGGLIN ANOMALY; MEGAKARYOCYTE; MICROTUBULE ASSEMBLY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PSEUDOPODIUM; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESIVENESS; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA; TRANSCRIPTION INITIATION;

ANIMALS; BLOOD PLATELETS; HEMATOPOIESIS; HUMANS; ISCHEMIA; MEGAKARYOCYTES; MICROSCOPY; MICROSCOPY, FLUORESCENCE; MICROTUBULES; MODELS, BIOLOGICAL; THROMBOCYTOPENIA; THROMBOCYTOSIS; TRANSCRIPTION, GENETIC;

EID: 31044443970     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI26891     Document Type: Review

References (79)

1. Ogawa, D. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood. 81:2844-2853.
2. Briddell, R., Brandt, J., Stravena, J., Srour, E., and Hoffman, R. 1989. Characterization of the human burst-forming unit-megakaryocyte. Blood. 59:145-151.
3. Kaushansky, K. 2005. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 115:3339-3347. doi:10.1172/JCI26674.
4. Kaushansky, K., and Drachman, J.G. 2002. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene. 21:3359-3367.
5. Long, M., Williams, N., and Ebbe, S. 1982. Immature megakaryocytes in the mouse: physical characteristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor. Blood. 59:569-575.
6. Odell, T.T., Jr., Jackson, C.W., and Reiter, R.S. 1968. Generation cycle of rat megakaryocytes. Exp. Cell Res. 53:321-328.
7. Ebbe, S. 1976. Biology of megakaryocytes. Prog. Hemost. Thromb. 3:211-229.
8. Ebbe, S., and Stohlman, F. 1965. Megakaryocytopoiesis in the rat. Blood. 26:20-34.
9. Ravid, K., Zimmet, J.M., and Jones, M.R. 2002. Roads to polyploidy: the megakaryocyte example. J. Cell. Physiol. 190:7-20.
10. Nagata, N., Muro, Y., and Todokoro, K. 1997. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J. Cell Biol. 139:449-457.
11. Vitrat, N., et al. 1998. Endomitosis of human megakaryocytes is due to abortive mitosis. Blood. 91:3711-3723.
12. Odell, T., Jackson, C., and Friday, T. 1970. Megakaryocytopoiesis in rats with special reference to polyploidy. Blood. 35:775-782.
13. Yamada, F. 1957. The fine structure of the megakaryocyte in the mouse spleen. Acta Anat. (Basel). 29:267-290.
14. Behnke, O. 1968. An electron microscope study of megakaryocytes of rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat. J. Ultrastruct. Res. 24:412-433.
15. Nakao, K., and Angrist, A. 1968. Membrane surface specialization of blood platelet and megakaryocyte. Nature. 217:960-961.
16. Gerrard, J., White, J., Rao, G., and Townsend, D. 1976. Localization of platelet prostaglandin production in the platelet dense tubular system. Am. J. Pathol. 101:353-364.
17. Henijnen, H.F., et al. 1998. Multivesicular bodies are an intermediate stage in the formation of platelet alpha granules. Blood. 91:2313-2325.
18. Handagama, P.J., George, M., Shuman, R., McEver, R., and Bainton, D.F. 1987. Incorporation of circulating protein into megakaryocyte and platelet granules. Proc. Natl. Acad. Sci. U. S. A. 84:861-865.
19. Radley, J.M., and Haller, J.C. 1982. The demarcation membrane system of the megakaryocyte: a misnomer? Blood. 60:213-219.
20. Wright, J. 1906. The origin and nature of blood platelets. Boston Med. Surg. J. 154:643-645.
21. Becker, R.P., and DeBruyn, P.P. 1976. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation: a scanning electron microscopic investigation. Am. J. Anat. 145:183-205.
22. Thiery, J., and Bessis, M. 1956. Genesis of blood platelets from the megakaryocytes in living cells [In French]. C. R. Hebd. Seances Acad. Sci. 242:290-292.
23. Behnke, O. 1969. An electron microscope study of the rate megakaryocyte. II. Some aspects of platelet release and microtubules. J. Ultrastruct. Res. 26:111-129.
24. Kaushansky, K. 2003. Thrombopoietin: a tool for understanding thrombopoiesis. J. Thromb. Haemost. 1:1578-1592.
25. Leven, R.M., and Nachmias, V.T. 1982. Cultured megakaryocytes: changes in the cytoskeleton after ADP-induced spreading. J. Cell Biol. 92:313-323.
26. Tablin, F., Castro, M., and Leven, R.M. 1990. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J. Cell Sci. 97:59-70.
27. Italiano, J.E., Lecine, P., Shivdasani, R., and Hartwig, J.H. 1999. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J. Cell Biol. 147:1299-1312.
28. Choi, E., Nichol, J.L., Hokom, M.M., Hornkohl, A.C., and Hunt, P. 1995. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood. 85:402-413.
29. Cramer, E., et al. 1997. Ultrastructure of platelet formation by human megakaryocytes cultured with Mpl ligand. Blood. 89:2336-2346.
30. Tavassoli, M., and Aoki, M. 1989. Localization of megakaryocytes in the bone marrow. Blood Cells. 15:3-14.
31. Scurfield, G., and Radley, J.M. 1981. Aspects of platelet formation and release. Am. J. Hematol. 10:285-296.
32. Lichtman, M., Chamberlain, J., Simon, W., and Santillo, P. 1978. Parasinusoidal location of megakaryocytes in marrow: a determinant of platelet release. Am. J. Hematol. 4:303-312.
33. Crispino, J.D. 2005. GATA-1 in normal and malignant hematopoiesis. Semin. Cell Dev. Biol. 16:137-147.
34. Shivdasani, R.A., Fujiwara, Y., McDevitt, M.A., and Orkin, S.H. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:3965-3973.
35. Mehaffey, M.G., Newton, A.L., Gandhi, M.J., Crossley, M., and Drachman, J.G. 2001. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood. 98:2681-2688.
36. Andrews, N.H., Erdjument-Bromage, H., Davidson, M., Tempest, P., and Orkin, S. 1993. Erythroid transcription factor NF-E2 is a hematopoietic-specific basic-leucine zipper protein. Nature. 362:722-728.
37. Shivdasani, R.A., et al. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocytes. Cell. 81:695-704.
38. Lecine, P., et al. 1998. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood. 92:1608-1616.
39. Lecine, P., Italiano, J.E., Kim, S., Villeval, J., and Shivdasani, R. 2000. Hematopoietic-specific beta1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood. 96:1366-1373.
40. Tiwari, S., et al. 2003. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood. 102:3970-3979.
41. Deveaux, S., et al. 1997. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes. EMBO J. 16:5654-5661.
42. Kerrigan, S.W., Gaur, M., Murphy, R.P., Shattil, S.J., and Leavitt, A.D. 2004. Caspase 12: a developmental link between G-protein-coupled receptors and integrin alphaIIbeta3 activation. Blood. 104:1327-1334.
43. Topp, K.S., Tablin, F., and Levin, J. 1990. Culture of isolated bovine megakaryocytes on reconstituted basement membrane matrix leads to proplatelet process formation. Blood. 76:912-924.
44. Schwer, H.P., Lecine, P., Tiwari, S., Italiano, J.E., and Hartwig, J. 2001. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr. Biol. 11:579-589.
45. Schulze, H., et al. 2004. Interactions between the megakaryocyte/ platelet-specific beta 1 tubulin and the secretory leukocyte protease inhibitor SLPI suggest a role for regulated proteolysis in platelet functions. Blood. 104:3949-3957.
46. Handagama, P.J., Feldman, B.F., Jain, N.C., Farver, T.B., and Kono, C.S. 1987. In vitro platelet release by rat megakaryocytes: effect of metabolic inhibitors and cytoskeletal disrupting agents. Am. J. Vet. Res. 48:1142-1146.
47. Freson, K., et al. 2005. The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. Blood. 106:2356-2362.
48. Italiano, J.E., Shivdasani, R.A., and Hartwig, J.H. 2002. Cytoskeletal mechanics of platelet formation [abstract]. Blood. 100:132a.
49. Patel, S.R., et al. 2005. Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood. doi:10.1182/blood- 2005-06-2204.
50. Trowbridge, E., et al. 1984. The origin of platelet count and volume. Clin. Phys. Physiol. Meas. 5:145-156.
51. Harker, L., and Finch, C. 1969. Thrombokinetics in man. J. Clin. Invest. 48:963-974.
52. Kaufman, R., Airo, R., Pollack, S., and Crosby, W. 1965. Circulating megakaryocytes and platelet release in the lung. Blood. 26:720-731.
53. Rojnuckarin, P., and Kaushansky, K. 2001. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase C alpha. Blood. 97:154-161.
54. Richardson, J., Shivdasani, R., Boers, C., Hartwig, J., and Italiano, J.E. 2005. Mechanisms of organelle transport and capture along proplatelets during platelet production. Blood. doi:10.1182/blood-2005-06-2206.
55. Gordge, M.P. 2005. Megakaryocyte apoptosis: sorting out the signals. Br. J. Pharmacol. 145:271-273.
56. Radley, J.M., and Haller, J.C. 1983. Fate of senescent megakaryocytes in the bone marrow. Br. J. Haematol. 53:277-287.
57. Falcieri, E., et al. 2000. Ultrastructural characterization of maturation, platelet release and senescence of human cultured megakaryocytes. Anat. Rec. 258:90-99.
58. Zauli, G., et al. 1997. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood. 90:2234-2243.
59. Kaluzhny, Y., and Ravid, K. 2004. Role of apoptotic processes in platelet biogenesis. Acta Haematol. 111:67-77.
60. De Botton, S., et al. 2002. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood. 100:1310-1317.
61. Kaluzhny, Y., et al. 2002. BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. Blood. 100:1670-1678.
62. Sanz, C., et al. 2001. Antiapoptotic protein Bcl-xL is up-regulated during megakaryocytic differentiation of CD34(+) progenitors but is absent from senescent megakaryocytes. Exp. Hematol. 29:728-735.
63. Battinelli, E., and Loscalzo, J. 2000. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood. 95:3451-3459.
64. Battinelli, E., Willoughby, S.R., Foxall, T., Valeri, C.R., and Loscalzo, J. 2001. Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 98:14458-14463.
65. Kim, J.A., et al. 2002. Gene expression profile of megakaryocytes from human cord blood CD34+ cells ex vivo expanded by thrombopoietin. Stem Cells. 20:402-416.
66. Clarke, M.C., Savill, J., Jones, D.B., Nobel, B.S., and Brown, S.B. 2003. Compartmentalized megakaryocyte death generates function platelets committed to caspase-independent death. J. Cell Biol. 160:577-587.
67. Brown, S.B., Clarke, M.C., Magowan, L., Sanderson, H., and Savill, J. 2000. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J. Biol. Chem. 275:5987-5996.
68. Bernard, J., and Soulier, J.P. 1948. Sur une nouvelle variet e de dystrophie thrombocytarie-hemorragipare congenitale. Sem. Hop. Paris. 24:3217-3223.
69. Balduini, C.L., and Savoia, A. 2002. Inherited thrombocytopenias: from genes to therapy. Haematologica. 87:860-880.
70. Ware, J., Russel, S., and Ruggeri, Z.M. 2000. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc. Natl. Acad. Sci. U. S. A. 97:2803-2808.
71. Poujol, C., Ware, J., Nieswandt, B., Nurden, A.T., and Nurden, P. 2002. Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model. Exp. Hematol. 30:352-360.
72. Franke, J.D., Dong, F., Rickoll, W.L., Kelley, M.J., and Kiehart, D.P. 2004. Rod mutations associated with MYH9-related disorders disrupt non-muscle myosin-IIA assembly. Blood. 105:161-169.
73. Hu, A., Wang, F., and Sellers, J.R. 2002. Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function. J. Biol. Chem. 277:46512-46517.
74. Hamilton, R.W., et al. 1980. Platelet function, ultrastructure, and survival in the May-Hegglin anomaly. Am. J. Clin. Pathol. 74:663-668.
75. Canobbio, I., Noris, P., Pecci, A., Balduini, C.L., and Torti, M. 2005. Altered cytoskeleton organization in platelets from patients with MYH9-related disease. J. Thromb. Haemost. 3:1026-1035.
76. DiPumpo, M., et al. 2002. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome. Haematologica. 87:943-947.
77. Raccuglia, G. 1971. Gray platelet syndrome. Am. J. Med. 51:818-828.
78. Oramer, E.M., Vainchenker, W., Vinci, G., Guichard, J., and Breton-Gorius, J. 1985. Gray platelet syndrome: immunoelectron microscopic localisation of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood. 66:1309-1316.
79. Stenberg, P.E., et al. 1998. Prolonged bleeding time with defective platelet filopodia formation in the Wistar Furth rat. Blood. 91:1599-1608.